.2
Annual General Meeting
of Chemomab Therapeutics Ltd.
|
Date:
|
April 28, 2026
|
|
|
See Voting Instruction On Reverse Side.
|
|
Please make your marks like this: ☒ Use dark black pencil or pen only
|
||||
|
|
|
For
|
Against
|
Abstain
|
|
1.
|
To re-elect each of Mr. Neil Cohen and Dr. Claude Nicaise as Class II directors, to hold office until the close of the Company’s
annual general meeting of shareholders in 2029, and until their respective successors are duly elected and qualified, or until their respective offices are vacated in accordance with our Articles of Association or the Israeli Companies Law,
5759-1999
|
|
|
|
|
|
|
|
|
|
|
|
1a. Mr. Neil Cohen
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
|
1b. Dr. Claude Nicaise
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
2.
|
To approve the compensation policy for office holders and directors;
|
☐
|
☐
|
☐
|
|
|
|
|
|
|
|
3.
|
To approve an increase of the Company’s authorized share capital and to amend the Company’s Articles accordingly; and
|
☐
|
☐
|
☐
|
|
4.
|
To approve the re-appointment of Somekh Chaikin, a member firm of KPMG International, as the Company’s independent registered
public accounting firm for the year ending December 31, 2026, and to authorize the Company’s board of directors (with power of delegation to its audit committee) to set the fees to be paid to such auditors.
|
☐
|
☐
|
☐
|
Authorized Signatures - This section must be
completed for your instructions to be executed.
|
__________________________________
|
__________________________________
|
|
Please Sign Here
|
Please Date Above
|
|
|
|
|
__________________________________
|
__________________________________
|
|
Please Sign Here
|
Please Date Above
|
↑ Please separate carefully at the perforation and return just this portion in the envelope provided. ↑
Annual General Meeting of Chemomab Therapeutics Ltd.
to be held on April 28, 2026
For Holders as of March 19, 2026
MAIL|
|
•
|
Mark, sign and date your Voting Instruction Form.
|
|
|
•
|
Detach your Voting Instruction Form.
|
|
|
•
|
Return your Voting Instruction Form in the
postage-paid envelope provided.
|
All votes must be received no later than 11:59 p.m. (EDT) on April 27, 2026.
|
|
PROXY TABULATOR FOR
|
|
|
CHEMOMAB THERAPEUTICS LTD.
|
|
|
P.O. BOX 8016
|
|
|
CARY, NC 27512-9903
|
|
|
|
|
EVENT #
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CLIENT #
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Copyright © 2025 Mediant Communications Inc. All Rights Reserved
Chemomab Therapeutics Ltd.
Instructions to The Bank of New York Mellon, as Depositary
Must be received no later than 11:59 p.m. (EDT) on April 27, 2026
The undersigned registered owner of American Depositary Shares hereby requests and instructs The Bank of New York Mellon, as Depositary,
to endeavor, insofar as practicable, to vote or cause to be voted the amount of Ordinary Shares or other Deposited Securities represented by such American Depositary Shares of Chemomab Therapeutics Ltd. registered in the name of the undersigned on the books of the Depositary as of the close of business on March 19, 2026 at the Annual General Meeting of the Shareholders of Chemomab Therapeutics Ltd. to be held on April 28, 2026, or any postponement or adjournment
thereof in respect of the resolutions specified on the reverse.
NOTES:
|
1.
|
Please direct the Depositary how it is to vote by placing an “X” in the appropriate box opposite each agenda
item.
|
|
|
PROXY TABULATOR FOR
CHEMOMAB THERAPEUTICS LTD.
P.O. BOX 8016
CARY, NC 27512-9903
|